Moderna Stock Wipes Out $14 Billion as MRNAon Crashes 30% From Record
Covered by 1 source · 1 article
Moderna shares plunged one day after their historic 177% rally, erasing approximately $14.2 billion from the biotechnology company’s market value as investors reassessed the valuation created by its cancer-treatment breakthrough. MRNA trade…
Covered by
